Bromberg, Jacoline E.C.
Erasmus MC Cancer Institute
2 papers on CoChatORCID 0000-0002-3830-7142
Most cited papers
- Verified
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 7,405
- Verified
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Baumert, B. G., Hegi, M. E., van den Bent, M. J., von Deimling, A., Gorlia, T., Hoang-Xuan, K., Brandes, A. A., Kantor, G., Taphoorn, M. J. B., Hassel, M. B., et al. (2016) · The Lancet Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 495
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free